查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1668158

运动医学血液生物标记市场 - 全球产业规模、份额、趋势、机会和预测，按类型、地区和竞争细分，2020-2030 年预测

Blood-based Biomarker For Sports Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球血液运动医学生物标记市场价值为 7.5845 亿美元，预计到 2030 年将达到 10.5772 亿美元，预测期内复合年增长率为 5.66%。随着医疗诊断技术的进步推动对个人化和精准运动员护理的需求，全球基于血液的运动医学生物标记市场正在快速成长。以血液为基础的生物标记因其能够即时了解运动员的生理状况、受伤风险和恢復进度而成为运动医学领域的热门话题。这些生物标记包括蛋白质、代谢物和基因标记，为监测运动表现和健康的各个方面提供了一种非侵入性和客观的手段。市场成长的主要驱动力之一是运动相关伤害的发生率不断增加。随着职业运动员和业余运动员力争达到最佳表现，肌肉拉伤、韧带撕裂和脑震盪等伤害变得很常见。血液中的生物标记能够早期发现组织损伤、发炎和压力相关的状况，从而及时采取干预措施，促进康復并防止进一步的併发症。此外，对个人化运动医学的日益重视推动了这些生物标记的采用，因为它们能够根据个人独特的生理反应制定个人化的训练和復健计划。

市场概况
预测期 2026-2030
2024 年市场规模 7.5845 亿美元
2030 年市场规模 10.5772亿美元
2025-2030 年复合年增长率 5.66%
成长最快的领域 肌酸激酶 (CK)
最大的市场 北美洲

生物技术和生物标誌物发现的进步也推动了市场的发展。对新型生物标记的持续研究扩大了可测量参数的范围，从肌酸激酶（CK）和乳酸脱氢酶（LDH）等肌肉损伤指标到C反应蛋白（CRP）和白细胞介素等氧化压力和发炎标记。这些创新不仅提高了诊断的准确性，而且还透过穿戴式和即时检测设备实现即时监控，进一步推动市场需求。

主要市场驱动因素

运动伤害增多，需要早期发现

主要市场趋势

技术进步

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：COVID-19 对全球运动医学血液生物标记市场的影响

第 5 章：全球基于血液的运动医学生物标记市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按类型（CK、肌红蛋白、乳酸、白血球、尿素、CRP、脂质和蛋白质氢过氧化物、IL-6、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第 6 章：北美运动医学血液生物标记物市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 墨西哥
    • 加拿大

第 7 章：欧洲运动医学血液生物标记市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区运动医学血液生物标记市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 印度
    • 韩国
    • 日本
    • 澳洲

第 9 章：南美洲运动医学血液生物标记物市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲运动医学血液生物标记市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如果有）
  • 最新动态

第 13 章：全球运动医学血液生物标记市场：SWOT 分析

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章：竞争格局

  • Abbott Laboratories
  • BIOMERIEUX
  • F. Hoffmann-La Roche Ltd.
  • ARUP Laboratories Inc.
  • Siemens Healthineers AG
  • RayBiotech, Inc
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc
  • Beckman Coulter, Inc.
  • Randox Laboratories Ltd.

第 16 章：策略建议

第17章 调査会社について・免责事项

简介目录
Product Code: 27717

Global Blood-based Biomarker For Sports Medicine Market was valued at USD 758.45 Million in 2024 and is expected to reach USD 1057.72 Million by 2030 with a CAGR of 5.66% during the forecast period. The global blood-based biomarker market for sports medicine is experiencing rapid growth as advancements in medical diagnostics drive the demand for personalized and precise athlete care. Blood-based biomarkers have gained traction in the field of sports medicine due to their ability to provide real-time insights into an athlete's physiological status, injury risks, and recovery progress. These biomarkers, which include proteins, metabolites, and genetic markers, offer a non-invasive and objective means of monitoring various aspects of athletic performance and health. One of the primary drivers of market growth is the increasing incidence of sports-related injuries. As professional and amateur athletes strive for peak performance, injuries such as muscle strains, ligament tears, and concussions have become common. Blood-based biomarkers enable early detection of tissue damage, inflammation, and stress-related conditions, allowing for timely interventions that can enhance recovery and prevent further complications. Additionally, the growing emphasis on personalized sports medicine has fueled the adoption of these biomarkers, as they enable tailored training and rehabilitation plans based on an individual's unique physiological responses.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 758.45 Million
Market Size 2030USD 1057.72 Million
CAGR 2025-20305.66%
Fastest Growing SegmentCreatine Kinase (CK)
Largest MarketNorth America

Advancements in biotechnology and biomarker discovery have also propelled the market forward. Continuous research into novel biomarkers has expanded the range of measurable parameters, from muscle damage indicators like creatine kinase (CK) and lactate dehydrogenase (LDH) to markers of oxidative stress and inflammation, such as C-reactive protein (CRP) and interleukins. These innovations are not only improving diagnostic accuracy but also facilitating real-time monitoring through wearable and point-of-care testing devices, further driving market demand.

Key Market Drivers

Rising Sports Injuries and Need for Early Detection

The increasing incidence of sports injuries across all levels of athletic participation is a major driver for the global blood-based biomarker for the sports medicine market. Athletes, both professional and amateur, are experiencing rising cases of muscle tears, ligament injuries, concussions, and stress fractures due to the growing intensity and competitiveness in sports. Traditional diagnostic methods, such as imaging techniques and physical assessments, often fail to detect early signs of damage, leading to delayed treatment and prolonged recovery periods. This has fueled the demand for blood-based biomarkers, which offer a minimally invasive and highly accurate means of detecting physiological and biochemical changes associated with sports-related injuries. According to the National Safety Council, in 2023, approximately 3.7 million individuals received emergency medical treatment for injuries related to sports and recreational equipment. The activities most commonly linked to these injuries include exercise, cycling, and basketball. One of the key advantages of blood-based biomarkers in sports medicine is their ability to provide early detection of injuries such as concussions and muscle damage. Biomarkers such as creatine kinase (CK), myoglobin, and C-reactive protein (CRP) can indicate muscle stress, inflammation, and tissue breakdown, allowing medical professionals to intervene before severe damage occurs. In addition, neuro biomarkers like S100 calcium-binding protein B (S100B) and tau protein are gaining attention for their role in detecting mild traumatic brain injuries (TBIs) in athletes, particularly in contact sports such as football, boxing, and rugby. The ability of these biomarkers to detect even subtle injuries has increased their adoption in sports medicine, as they facilitate personalized treatment plans and prevent long-term complications.

Key Market Trends

Technological Advancements

The blood-based biomarker for sports medicine market is witnessing significant growth, driven primarily by advancements in technology. These innovations are reshaping how biomarkers are detected, analyzed, and utilized in sports medicine to enhance athlete performance, injury prevention, and recovery monitoring. With the integration of cutting-edge diagnostic tools, artificial intelligence (AI), and wearable biosensors, the landscape of sports medicine is undergoing a transformation, making blood-based biomarkers more efficient and accessible. One of the major breakthroughs in this field is the development of high-sensitivity detection techniques, such as next-generation sequencing (NGS), mass spectrometry, and microfluidic platforms. These technologies have enhanced the precision of biomarker identification, allowing for early detection of muscle fatigue, inflammation, and potential injuries. NGS, for instance, enables comprehensive genomic and proteomic analysis from small blood samples, providing detailed insights into an athlete's physiological state. Similarly, mass spectrometry has improved the accuracy of biomarker quantification, leading to more reliable assessments of biochemical changes associated with sports-related stress and injuries.

Key Market Players

  • Abbott Laboratories
  • BIOMERIEUX
  • F. Hoffmann-La Roche Ltd.
  • ARUP Laboratories Inc.
  • Siemens Healthineers AG
  • RayBiotech, Inc
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc
  • Beckman Coulter, Inc.
  • Randox Laboratories Ltd.

Report Scope

In this report, the Global Blood-based Biomarker For Sports Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood-based Biomarker For Sports Medicine Market, By Type:

  • CK
  • Myoglobin
  • Lactate
  • WBC
  • Urea
  • CRP
  • Lipid and Protein Hydroperoxides
  • IL-6
  • Others

Blood-based Biomarker For Sports Medicine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood-based Biomarker For Sports Medicine Market.

Available Customizations:

Global Blood-based Biomarker For Sports Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Blood-based Biomarker For Sports Medicine Market

5. Global Blood-based Biomarker For Sports Medicine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6, Others)
    • 5.2.2. By Region
    • 5.2.3. By Company (2024)
  • 5.3. Market Map

6. North America Blood-based Biomarker For Sports Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood-based Biomarker For Sports Medicine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
    • 6.3.2. Mexico Blood-based Biomarker For Sports Medicine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
    • 6.3.3. Canada Blood-based Biomarker For Sports Medicine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End Use

7. Europe Blood-based Biomarker For Sports Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
    • 7.3.2. Germany Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
    • 7.3.3. United Kingdom Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
    • 7.3.4. Italy Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
    • 7.3.5. Spain Blood-based Biomarker For Sports Medicine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type

8. Asia Pacific Blood-based Biomarker For Sports Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
    • 8.3.2. India Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
    • 8.3.3. South Korea Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
    • 8.3.4. Japan Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
    • 8.3.5. Australia Blood-based Biomarker For Sports Medicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type

9. South America Blood-based Biomarker For Sports Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Blood-based Biomarker For Sports Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
    • 9.3.2. Argentina Blood-based Biomarker For Sports Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
    • 9.3.3. Colombia Blood-based Biomarker For Sports Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type

10. Middle East and Africa Blood-based Biomarker For Sports Medicine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Blood-based Biomarker For Sports Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
    • 10.3.2. Saudi Arabia Blood-based Biomarker For Sports Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
    • 10.3.3. UAE Blood-based Biomarker For Sports Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Blood-based Biomarker For Sports Medicine Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. BIOMERIEUX
  • 15.3. F. Hoffmann-La Roche Ltd.
  • 15.4. ARUP Laboratories Inc.
  • 15.5. Siemens Healthineers AG
  • 15.6. RayBiotech, Inc
  • 15.7. Thermo Fisher Scientific, Inc.
  • 15.8. Bio-Rad Laboratories, Inc
  • 15.9. Beckman Coulter, Inc.
  • 15.10. Randox Laboratories Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer